Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020

BACKGROUND: The novel SARS-CoV-2 has caused the coronavirus disease 2019 (COVID-19) pandemic. Currently, with insufficient worldwide vaccination rates, identifying treatment solutions to reduce the impact of the virus is urgently needed. METHOD: An adaptive, multicentric, open-label, and randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventura-Carmenate, Yendry, Alkaabi, Fatima Mohammed, Castillo-Aleman, Yandy Marx, Villegas-Valverde, Carlos Agustin, Ahmed, Yasmine Maher, Sanna, Pierdanilo, Almarzooqi, Ayesha Abdulla, Abdelrazik, Abeer, Torres-Zambrano, Gina Marcela, Wade-Mateo, Maura, Quesada-Saliba, David, Abdel Hadi, Loubna, Bencomo-Hernandez, Antonio Alfonso, Rivero-Jimenez, Rene Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563822/
https://www.ncbi.nlm.nih.gov/pubmed/34746417
http://dx.doi.org/10.1186/s41231-021-00101-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563822/
https://www.ncbi.nlm.nih.gov/pubmed/34746417
http://dx.doi.org/10.1186/s41231-021-00101-5

Ejemplares similares